Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2026-02-24 @ 12:14 AM
Study NCT ID:
NCT00564161
Status:
WITHDRAWN
Last Update Posted:
2016-09-02
First Post:
2007-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'bioSpec': {'retention': 'SAMPLES_WITHOUT_DNA', 'description': 'CSF.'}, 'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 0}}, 'statusModule': {'overallStatus': 'WITHDRAWN', 'startDateStruct': {'date': '2008-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2007-11', 'completionDateStruct': {'date': '2009-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2016-09-01', 'studyFirstSubmitDate': '2007-11-25', 'studyFirstSubmitQcDate': '2007-11-26', 'lastUpdatePostDateStruct': {'date': '2016-09-02', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2007-11-27', 'type': 'ESTIMATED'}}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Preterm Infants With White Matter Damage', 'Preterm Infants Developing Normally']}, 'descriptionModule': {'briefSummary': 'We hypothesize that misexpression of vascular endothelial growth factor (VEGF) in the Cerebrospinal fluid of preterm infants can be used as a biomarker to predict the risk for developing white matter damage.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD'], 'maximumAge': '40 Weeks', 'minimumAge': '25 Weeks', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'preterm infants.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Preterm infants undergoing lumbar puncture.\n\nExclusion Criteria:\n\n* Preterm with IVH or known infection or meningitis.'}, 'identificationModule': {'nctId': 'NCT00564161', 'briefTitle': 'VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants', 'organization': {'class': 'OTHER', 'fullName': 'Hadassah Medical Organization'}, 'officialTitle': 'VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants', 'orgStudyIdInfo': {'id': '606060-HMO-CTIL'}, 'secondaryIdInfos': [{'id': '606060-HMO-CTIL'}]}, 'armsInterventionsModule': {'armGroups': [{'label': '1'}, {'label': '2'}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Talya Dor, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Hadassah Medical Organization'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Hadassah Medical Organization', 'class': 'OTHER'}}}}